US OptionsDetailed Quotes
LLY240712P820000
- 0.02
- 0.000.00%
15min DelayClose Jul 12 12:00 ET
0.36High0.02Low
0.36Open0.02Pre Close12 Volume178 Open Interest820.00Strike Price364.00Turnover478.96%IV13.54%PremiumJul 12, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type-0.0015Delta0.0001Gamma47420.00Leverage Ratio-2.3830Theta0.0000Rho-70.13Eff Leverage0.0005Vega
Eli Lilly and Co Stock Discussion
Sign in to post a comment
Why do you think $Pfizer(PFE.US$ decided to progress with Danuglipron? (![]()
Can't give up this huge market?
The P2 data they published in obese, non-diabetics doesn't look too good. Danuglipron twice daily compared with $Eli Lilly and Co(LLY.US$ Orforglipron and $Structure Therapeutics(GPCR.US$ GSBR 1290 at week 12: Orforglipron seems to be the best non-peptide GLP-1 RA
The P2 data they published in obese, non-diabetics doesn't look too good. Danuglipron twice daily compared with $Eli Lilly and Co(LLY.US$ Orforglipron and $Structure Therapeutics(GPCR.US$ GSBR 1290 at week 12: Orforglipron seems to be the best non-peptide GLP-1 RA
+1
5
Jim Cramer on Wednesday reviewed eight stocks that could join the “trillion-dollar stock club,” pinpointing pharmaceutical giant Eli Lilly and electric vehicle maker Tesla as top contenders.
Currently, tech giants $Apple(AAPL.US$ , $Microsoft(MSFT.US$ , $NVIDIA(NVDA.US$ , $Alphabet-A(GOOGL.US$ , $Amazon(AMZN.US$ , and $Meta Platforms(META.US$ are the only companies to surpass $1 trillion in market cap.
$Eli Lilly and Co(LLY.US$ : Cramer ...
Currently, tech giants $Apple(AAPL.US$ , $Microsoft(MSFT.US$ , $NVIDIA(NVDA.US$ , $Alphabet-A(GOOGL.US$ , $Amazon(AMZN.US$ , and $Meta Platforms(META.US$ are the only companies to surpass $1 trillion in market cap.
$Eli Lilly and Co(LLY.US$ : Cramer ...
From YouTube
12
3
All these stocks hit new 52 WEEK HIGHS at some point today
Apple $AAPL
Google $GOOGL
Eli Lilly $LLY
Walmart $WMT
Palantir $PLTR
$ASML
Citi $C
Royal Caribbean $RCL
Trade Desk $TTD
Morgan Stanley $MS
Lam Research $LRCX
Applied Materials $AMAT
Agnico Eagle $AEM
Alnylam $ALNY
Digital Realty $DLR
Corning $GLW
$ICE
Insmed $INSM
Iron Mountain $IRM
Jefferies $JEF
Kinross Gold $KGC
KLA Corp $KLAC
Lantheus $LNTH
Altria $MO
Motorola $MSI
Netapp $NTAP
$NU
Novartis $NVS
Public Service $PEG
P...
Apple $AAPL
Google $GOOGL
Eli Lilly $LLY
Walmart $WMT
Palantir $PLTR
$ASML
Citi $C
Royal Caribbean $RCL
Trade Desk $TTD
Morgan Stanley $MS
Lam Research $LRCX
Applied Materials $AMAT
Agnico Eagle $AEM
Alnylam $ALNY
Digital Realty $DLR
Corning $GLW
$ICE
Insmed $INSM
Iron Mountain $IRM
Jefferies $JEF
Kinross Gold $KGC
KLA Corp $KLAC
Lantheus $LNTH
Altria $MO
Motorola $MSI
Netapp $NTAP
$NU
Novartis $NVS
Public Service $PEG
P...
1
tq 
Fed Chair Powell’s dovish testimony before Congress pushed U.S. stocks to new highs, with $S&P 500 Index(.SPX.US$ and Nasdaq 100 hitting record highs for five consecutive days, and $Nasdaq Composite Index(.IXIC.US$rising for six consecutive days. $Tesla(TSLA.US$ 's ten-day rally has boosted its value by over 43%, adding nearly $240 billion in market cap. The semiconductor index rose 1% before closing down. $NVIDIA(NVDA.US$ opened over 4% higher and closed up 2.5%. $Apple(AAPL.US$ , Lam Res...
7
This article covers the catalysts for more share price growth and what is ahead for Tesla.
Tesla $Tesla(TSLA.US$ has reclaimed its post as the 10th biggest company in the US and if it reports better than expected results and outlook on July 23, it could overthrow Broadcom $Broadcom(AVGO.US$, and Eli Lily $Eli Lilly and Co(LLY.US$ and possibly Berkshi...
Tesla $Tesla(TSLA.US$ has reclaimed its post as the 10th biggest company in the US and if it reports better than expected results and outlook on July 23, it could overthrow Broadcom $Broadcom(AVGO.US$, and Eli Lily $Eli Lilly and Co(LLY.US$ and possibly Berkshi...
+2
10
3
How does Eli Lilly $Eli Lilly and Co(LLY.US$ follow up on gains of close to 60% in 2023 and so far in 2024? By winning a major U.S. Food and Drug Administration (FDA) approval.
Last week, the FDA approved Lilly's Kisunla (donanemab) in treating early symptomatic Alzheimer's disease. Is Eli Lilly stock a no-brainer buy after this key FDA approval?
How big is Lilly's FDA win?
There are now eight FDA-approved treatments for Alz...
Last week, the FDA approved Lilly's Kisunla (donanemab) in treating early symptomatic Alzheimer's disease. Is Eli Lilly stock a no-brainer buy after this key FDA approval?
How big is Lilly's FDA win?
There are now eight FDA-approved treatments for Alz...
12
No comment yet
I Am 102927471 :